GSK plc (GLAXF) Financial Statements

GSK plc (GLAXF) files with the U.S. Securities and Exchange Commission under CIK 0001131399. 10KGenie shows its annual statements from SEC filings.

Key Figures, Fiscal Year 2025

Revenue
32.67 billion GBP
Net Income
6.29 billion GBP
Total Assets
61.12 billion GBP
Net Cash from Operations
7.74 billion GBP

Fiscal year ended Dec 31, 2025. Latest periodic SEC filing: Mar 6, 2026. Source: SEC filings (EDGAR XBRL). Amounts in GBP.

Open the full financial statements for GLAXF in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History